Cargando…

The Impact of Infused Autograft Absolute Numbers of Immune Effector Cells on Survival Post-Autologous Stem Cell Transplantation

Autologous stem cell transplantation treatment has been viewed as a therapeutic modality to enable the infusion of higher doses of chemotherapy to eradicate tumor cells. Nevertheless, recent reports have shown that, in addition to stem cells, infusion of autograft immune effector cells produces an a...

Descripción completa

Detalles Bibliográficos
Autor principal:	Porrata, Luis F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315986/ https://www.ncbi.nlm.nih.gov/pubmed/35883639 http://dx.doi.org/10.3390/cells11142197

Ejemplares similares

Infused autograft lymphocyte-to-monocyte ratio and survival in T-cell lymphoma post-autologous peripheral blood hematopoietic stem cell transplantation
por: Porrata, Luis F., et al.
Publicado: (2015)

Natural Killer Cells Are Key Host Immune Effector Cells Affecting Survival in Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation
por: Porrata, Luis F.
Publicado: (2022)

Infused autograft lymphocyte to monocyte ratio predicts survival in classical Hodgkin lymphoma
por: Porrata, Luis F, et al.
Publicado: (2015)

Day 100 Peripheral Blood Absolute Lymphocyte/Monocyte Ratio and Survival in Classical Hodgkin's Lymphoma Postautologous Peripheral Blood Hematopoietic Stem Cell Transplantation
por: Porrata, Luis F., et al.
Publicado: (2013)

Timing of autologous stem cell transplantation from last chemotherapy affects lymphocyte collection and survival in non-Hodgkin lymphoma
por: Holtan, Shernan G, et al.
Publicado: (2006)

Interleukin-15 Affects Patient Survival through Natural Killer Cell Recovery after Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin Lymphomas
por: Porrata, Luis F., et al.
Publicado: (2010)

Hepatosplenic mucormycosis post autologous stem cell transplant
por: Yasmeen, Samia, et al.
Publicado: (2017)

P1338: INFUSION OF DIMETHYL SULFOXIDE (DMSO) - DEPLETED AUTOLOGOUS PERIPHERAL BLOOD PROGENITOR CELLS REDUCES POST-AUTOGRAFTING SEVERE GASTRIC TOXICITIES AND HOSPITALIZATION LENGTH
por: Filipponi, V., et al.
Publicado: (2022)

Myeloablative treatment supported by autologous stem cell infusion with neuroblastoma.
por: Ryu, Kyung Ha, et al.
Publicado: (2003)

Infusion of Autologous Retrodifferentiated Stem Cells into Patients with Beta-Thalassemia
por: Abuljadayel, Ilham Saleh, et al.
Publicado: (2006)

Early antimicrobial prophylaxis in autologous stem cell transplant recipients: Conventional versus an absolute neutrophil count‐driven approach
por: Horowitz, Justin G., et al.
Publicado: (2021)

Outcomes of Patients With Classic Hodgkin Lymphoma Who Relapsed After Autologous Stem Cell Transplant
por: Tun, Aung M., et al.
Publicado: (2023)

Post-Autologous (ASCT) Stem Cell Transplant Therapy in Multiple Myeloma
por: Al-Mansour, Zeina, et al.
Publicado: (2014)

Autologous Graft-versus-Tumor Effect: Reality or Fiction?
por: Porrata, Luis F.
Publicado: (2016)

Increased Immune-Regulatory Receptor Expression on Effector T Cells as Early Indicators of Relapse Following Autologous Stem Cell Transplantation for Multiple Myeloma
por: Lee, Lydia, et al.
Publicado: (2021)

Peripheral Blood Immune Cell Composition After Autologous MSC Infusion in Kidney Transplantation Recipients
por: Hendriks, Sanne H., et al.
Publicado: (2023)

The use of mitomycin C with autologous limbal-conjunctival autograft transplantation for management of recurrent pterygium
por: Fakhry, Mohamed A
Publicado: (2011)

Small Centers with Big Ventures: Autologous Stem Cell Transplantation Survival Data
por: Abid, Muhammad Bilal, et al.
Publicado: (2019)

Unexpected debris after post thawing donor stem cells in autologous transplantation
por: Aksoy, Basak Adaklı, et al.
Publicado: (2021)

Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30(+) lymphoma
por: Zhang, Peiling, et al.
Publicado: (2022)

Improvement in Post-Autologous Stem Cell Transplant Survival of Multiple Myeloma Patients: A Long-Term Institutional Experience
por: Nunnelee, Jordan, et al.
Publicado: (2022)

Treatment of primary pterygium: Role of limbal stem cells and conjunctival autograft transplantation
por: Mahdy, Mohamed A. E. Soliman, et al.
Publicado: (2009)

Long‐term outcome of immunologic autograft engineering
por: Porrata, Luis F., et al.
Publicado: (2022)

The impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency
por: Zekri, Abdel-Rahman N., et al.
Publicado: (2015)

Selected memory T cells infused post–haploidentical hematopoietic stem cell transplantation persist and hyperexpand
por: van Beek, Jasper J. P., et al.
Publicado: (2022)

Autologous Stem Cell Transplant for AL Amyloidosis
por: Roy, Vivek
Publicado: (2012)

Autologous Stem Cell Transplantation for Aggressive Lymphomas
por: Visani, Giuseppe, et al.
Publicado: (2012)

Polyomavirus Nephropathy in Autologous Stem Cell Transplantation
por: Malavade, Tushar, et al.
Publicado: (2018)

Becoming an Autologous Stem Cell Transplant Patient
por: Halpin, Sean, et al.
Publicado: (2020)

Obesity is associated with an impaired survival in lymphoma patients undergoing autologous stem cell transplantation
por: Scheich, Sebastian, et al.
Publicado: (2019)

Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
por: Bird, Sarah A., et al.
Publicado: (2020)

Hypomagnesemia at the time of autologous stem cell transplantation for patients with diffuse large B-cell lymphoma is associated with an increased risk of failure
por: Gile, Jennifer J., et al.
Publicado: (2021)

296 A Pilot Study of Hand Autografts Treated with Autologous Skin Cell Suspension
por: Deville, Paige, et al.
Publicado: (2023)

Osteochondral autograft transplantation versus autologous bone-cartilage paste grafting for the treatment of knee osteochondritis dissecans
por: Di Martino, Alessandro, et al.
Publicado: (2020)

Post Transplantation Cyclophosphamide Improves Outcome of Autologous Hematopoietic Stem Cell Transplantation in Animal Model of Multiple Sclerosis
por: Kasarełło, Kaja, et al.
Publicado: (2021)

Missing ligand model in autologous stem cell transplantation
por: Stern, M, et al.
Publicado: (2008)

Autologous stem cell transplantation for the treatment of neuroblastoma in Korea.
por: Ryu, Kyung Ha, et al.
Publicado: (2003)

Autologous haematopoietic stem cell transplantation for neurological diseases
por: Burman, Joachim, et al.
Publicado: (2018)

Autologous Stem Cell Transplantation for Myeloma: Cytoreduction or an Immunotherapy?
por: Minnie, Simone A., et al.
Publicado: (2021)

Autologous stem cell transplantation in a patient with scleromyxedema
por: Nathan, Sunita, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8b178e1fg2m76mtg24e0q088rq